Gastroesophageal Reflux Disease

Oncology·MeSH: Gastroesophageal Reflux

11 drugs in development·10 companies·1 clinical trial

Drug Pipeline by Phase

Approved(11)

Drug	Company
dexlansoprazole	Mylan II B.V. (MYL)
famotidine	ENGENE HOLDINGS INC. (ENGN)
famotidine	Avita Medical Inc. (RCEL)
famotidine	Mersana Therapeutics, Inc. (MRSN)
famotidine	SUNSET ISLAND GROUP (SUN)
famotidine	Seagen Inc. (SGEN)
famotidine	Miromatrix Medical Inc. (MIRO)
inFoods® (IBS)	BIOMERICA INC (BMRA)
pantoprazole	EXELIXIS, INC. (EXEL)
pantoprazole	SUNSET ISLAND GROUP (SUN)
VOQUEZNA	Phathom Pharmaceuticals, Inc. (PHAT)

BioSniper tracks 11 drugs in development for Gastroesophageal Reflux Disease across 10 companies.

There are 1 clinical trial targeting Gastroesophageal Reflux Disease tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.